SERA:NASDAQSera Prognostics, Inc. Analysis
Data as of 2026-08-31 - not real-time
$2.09
Latest Price
9/10Risk
Risk Level: High
Executive Summary
The moving-average structure behind Sera Prognostics, Inc. is neutral at $2.09, with no clear ordering between short and long averages. Relative strength is 53.0 — neutral — and the MACD signal is bullish. Watch $1.85 as support and $2.21 as the nearer resistance level.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. The average analyst target implies 162.7% above today's level. Revenue is growing at 76.5%.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 59.3%, a beta of 0.97 and a maximum drawdown of 57.6%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
The horizons line up on hold — conviction 2 out of 10.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. The average analyst target implies 162.7% above today's level. Revenue is growing at 76.5%.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 59.3%, a beta of 0.97 and a maximum drawdown of 57.6%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
The horizons line up on hold — conviction 2 out of 10.
Top Market Events
Updated Aug 12, 2026 0 SALT LAKE CITY, Aug.SERA PROGNOSTICS REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS.SALT LAKE CITY, Aug. 12, 2026 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® Nasdaq: SERA , focused on...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Trading below the 200-day average of 2.40
- MACD momentum is positive
- 30-day volatility of 59.3%
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Trading below the 200-day average of 2.40
- Analyst targets imply +162.7% versus the current price
- 30-day volatility of 59.3%
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- Analyst targets imply +162.7% versus the current price
- Negative return on equity of -45.0%
- Revenue growth of +76.5%
Key Metrics & Analysis
Financial Health
Revenue Growth76.50%
P/E Ratio-3.9
ROE-45.03%
ROA-23.48%
Debt/Equity5.05
P/B Ratio1.4
Op. Cash Flow$-27682000
Free Cash Flow$-18889624
Industry P/E30.3
Technical Analysis
TrendNeutral
RSI53.0
Support$1.85
Resistance$2.21
MA 20$2.04
MA 50$2.02
MA 200$2.40
MACDBullish
VolumeDecreasing
Fear & Greed Index94.14
Valuation
Target Price$5.50
Upside/Downside162.69%
GradeFair
TypeBlend
Risk Assessment
Beta0.97
Volatility59.26%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.